Announcements Trials

Browse Landscape

Phase

Status

Completed 7 Active not recruiting 5 Recruiting 2 Withdrawn 1

Sponsor Class

OTHER 14 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Non-small Cell Lung Cancer 1

Interventions

Cisplatin 14 Radiotherapy 13 Oxaliplatin 8 Fluorouracil 7 Gemcitabine 6 Drug Therapy 6 Leucovorin 5 Doxorubicin 5 Cytarabine 5 Cyclophosphamide 5 Carboplatin 5 Capecitabine 5 durvalumab 4 Paclitaxel 4 Etoposide 4 Docetaxel 4 Chemotherapy, Adjuvant 4 Biological Therapy 4 bicalutamide 3 Rituximab 3 Radiotherapy, Intensity-Modulated 3 Polymerase Chain Reaction 3 Platinum 3 Peripheral Blood Stem Cell Transplantation 3 Methylprednisolone 3 Gene Expression Profiling 3 Dexamethasone 3 Bortezomib 3 Biopsy 3 1,2-diaminocyclohexaneplatinum II citrate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × NETWORK × tremelimumab × Clear all

NCT03319316 2022-01-10

SOLUTION

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Withdrawn

Squamous Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡